Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Feb;9(2):DC16-20.
doi: 10.7860/JCDR/2015/12152.5585. Epub 2015 Feb 1.

Skin and Soft Tissue Infections due to Shewanella algae - An Emerging Pathogen

Jampala Srinivas  1 , Meera Pillai  2 , Vivek Vinod  3 , R Kavitha Dinesh  4
Affiliations

Skin and Soft Tissue Infections due to Shewanella algae - An Emerging Pathogen

Jampala Srinivas et al. J Clin Diagn Res. 2015 Feb.

Abstract

Introduction: Shewanella spp. are emerging human pathogens, the predominant species being Shewanella algae. Shewanella skin and soft tissue infections are more commonly seen in immunocompromised patients with a pre-existing cutaneous ulcer and most often associated with exposure to marine environments.

Aim: The study was conducted to investigate the epidemiological and clinical characteristics of Shewanella skin and soft tissue infections (SSTIs) for a period of five years.

Materials and methods: All Gram-negative non-fermenting motile isolates which produced pigmented colonies and positive for oxidase and H2S were further identified with Vitek 2 system.

Results: A total of 16 patients with SSTIs due to Shewanella species were identified during the period from 2010 to 2014. Majority of patients were urban, elderly and fisher men. Shewanella algae (n=12, 75%) was the predominant isolate. Skin or mucosal portal of entry was found in all patients and seawater contact was recorded in 56.25% of the patients. 81% of infections were polymicrobial, common concomitant pathogens being gut and marine flora. Peripheral vascular diseases were the predominant risk factors with comorbidities like diabetes, hypertension and hepatobiliary diseases. Third generation cephalosporins, meropenem and gentamicin were the most effective antibiotics while two of the isolates were multidrug resistant. 75% of the infected patients recovered completely and three patients died of complications.

Conclusion: Shewanella algae should be considered as an emerging pathogen of SSTIs mainly in patients with chronic ulcers and at times be multidrug resistant. These infections have a good clinical outcome if prompt medical, surgical and supportive treatment is offered.

Keywords: Comorbidities; Infections; Marine flora; Non-fermenters; Polymicrobial; Shewanella species.

PubMed Disclaimer

Figures

[Table/Fig-2]:
[Table/Fig-2]:
Graph showing portals of entry for SSTI due to Shewanella
[Table/Fig-3]:
[Table/Fig-3]:
Trends in prevalence of Shewanella SSTIs during 5 years period
[Table/Fig-4]:
[Table/Fig-4]:
Seasonal trends of Shewanella SSTIs in present study
[Table/Fig-5]:
[Table/Fig-5]:
Antibiotic resistance pattern of Shewanella isolates from SSTIs CS = Cefoperazone-Sulbactam; PT = Piperacillin-Tazobactam; TMP/SMZ = Trimethoprim- Sulfamethoxazole; AS = Ampicillin-Sulbactam
See this image and copyright information in PMC

References

    1. Koneman’s color atlas and textbook of diagnostic microbiology. New York: Lippincott; 2006. The non-fermentative gram-negative bacilli. In: Winn WC, Allen SD, Janda WM, Koneman EW, Precop GW, Schreckenberger PC, editors; pp. 336–37.
    1. Simidu U, Kita-Tsukamoto K, Yasumoto T, Yotsu M. Taxonomy of four marine bacterial strains that produce tetrodotoxin. Int J Syst Bacteriol. 1990;40(4):331–36. - PubMed
    1. Khashe S, Janda JM. Biochemical and pathogenic properties of Shewanella alga and Shewanella putrefaciens. J Clin Microbiol. 1998;36(3):783–87. - PMC - PubMed
    1. Holt HM, Gahrn-Hansen B, Bruun B. Shewanella algae and Shewanella putrefaciens: clinical and microbiological characteristics. Clin Microbiol Infect. 2005;11(5):347–52. - PubMed
    1. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing—Twenty- Second Informational Supplement. 1. M100-S23; 33. Wayne Pennsylvania, USA: CLSI; 2013. pp. 70–71.

LinkOut - more resources